Kian Kani

Medicine · Health Sciences

15h-index4.7kcitations62works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(34), HER2/EGFR in Cancer Research(25), Cancer, Hypoxia, and Metabolism(15), Advanced Proteomics Techniques and Applications(12), Cytokine Signaling Pathways and Interactions(10)

Publications62 total

Supplementary Figure Legend and Methods from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Supplementary Table 3 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Data from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Supplementary Figure Legend and Methods from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Supplementary Figure 2 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Data from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Supplementary Figure 3 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Supplementary Figure 3 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Data from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Table S3 from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Table S1 from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Supplementary Figure 2 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Table S5 from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Table S2 from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Table S3 from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Supplementary Table 2 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Supplemental Materials and Methods from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Supplementary Figure 1 from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
Table S5 from JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
2023Open Access
Data from Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Parag Mallick(32), David B. Agus(27), Lindsey D. Hughes(23), Mitchell E. Gross(19), Jonathan E. Katz(18), Carolina Garri(17), Vítor M. Faça(15), Samir Hanash(15), Katrin Tiemann(14), Roland Luethy(14), Sharon J. Pitteri(14), Qiaojun Fang(14), Wenxuan Zhang(14), Anjali Jain(14), Martin McIntosh(14), Babak Shahbaba(13), Jonathan Erde(13), Sylvia K. Plevritis(13), Paymaneh D. Malihi(12), Qing Zhang(12)